This study focuses on patients who have experienced an intracerebral hemorrhage, which is a type of stroke where bleeding occurs inside the brain tissue. The research examines the effectiveness of antiplatelet therapy using two medications: clopidogrel (75 mg daily) and acetylsalicylic acid (80 mg daily), which are drugs that help prevent blood clots from forming.
The purpose of this research is to determine whether starting oral antiplatelet medication alone is more beneficial than avoiding these medications in preventing future cardiovascular and brain-related health events in people who have survived a brain hemorrhage. The study compares two groups of patients – one group receiving antiplatelet medication and another group receiving standard care without antiplatelet medication.
The treatment period lasts for 60 months, during which patients will take their assigned medication daily. Throughout the study, doctors will monitor patients for various health events, particularly focusing on strokes, heart attacks, and other cardiovascular conditions. The medications are taken as tablets by mouth once daily.
Belgium 
The Netherlands 